News Image

INNOVATE Corp. Announces Fourth Quarter and Full Year 2024 Results

Provided By GlobeNewswire

Last update: Mar 31, 2025

- Infrastructure: DBM Global fourth quarter revenue of $225.7 million -
- Life Sciences: MediBeacon® Transdermal GFR (TGFR) system received FDA approval to assess kidney function -
- Spectrum: Broadcasting achieved double-digit revenue growth in the fourth quarter and full year 2024 -

Read more at globenewswire.com

INNOVATE CORP

NYSE:VATE (7/25/2025, 10:29:33 AM)

5.74

+0.04 (+0.7%)



Find more stocks in the Stock Screener

Follow ChartMill for more